You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer

  • Technology appraisal guidance
  • Reference number: TA227
  • Published:  29 June 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): appeal decision

Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): appeal decision Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): appeal decision
29 June 2011
(220.36 Kb 4 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 29 June 2011

Back to top